Shopping Cart
Remove All
Your shopping cart is currently empty
PAR650097 is a humanized monoclonal antibody targeting PAR2, used in migraine research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $195 | - | In Stock | |
| 5 mg | $483 | - | In Stock | |
| 10 mg | $692 | - | In Stock | |
| 25 mg | $1,080 | - | In Stock | |
| 50 mg | $1,490 | - | In Stock |
| Description | PAR650097 is a humanized monoclonal antibody targeting PAR2, used in migraine research. |
| Targets&IC50 | PAR2 (Ms):0.22 nM, PAR2 (human):0.58 nm |
| In vitro | PAR650097 has a high affinity for human PAR2 with KD value =833 pM PAR650097 effectively inhibits trypsin-driven activation of PAR2 with IC50 of 0.58 or 0.22 nM, respectively. [1] |
| In vivo | Intravenous administration of PAR650097 (100 mg/kg for 7 days) in rats achieved systemic exposure equivalent to high multiples of IC50 in vitro. The half-life is about 1-2 days. [1] |
| Synonyms | PAR650097, PAR 650097 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Molecular Weight | 145.5kDa |
| Smiles | #N/A |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.